InMed Pharmaceuticals Stock (NASDAQ:INM), Quotes and News Summary

Q: What sector and industry does InMed Pharmaceuticals (INM) operate in?

InMed Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

InMed Pharmaceuticals Stock (NASDAQ: INM) stock price, news, charts, stock research, profile.

Open	$0.245
Close	$0.230
Volume / Avg.	476.047K / 367.518K
Day Range	0.228 - 0.250
52 Wk Range	0.250 - 2.080
Market Cap	$1.424M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	0.17%
Days to Cover	1

Recent News

Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

InMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying

The Dow Jones index closed higher by over 450 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying

The Dow Jones index closed higher by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About

Sector

Healthcare

Industry

N/A

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy InMed Pharmaceuticals (INM) stock?

You can purchase shares of InMed Pharmaceuticals (NASDAQ: INM) through any online brokerage.

View our list of the best stock brokerages.

Who are InMed Pharmaceuticals's (INM) competitors?

There are no as such competitors for InMed Pharmaceuticals.

What is the target price for InMed Pharmaceuticals (INM) stock?

The latest price target for InMed Pharmaceuticals (NASDAQ: INM) was reported by HC Wainwright & Co. on Monday, November 29, 2021. The analyst firm set a price target for 6.00 expecting INM to rise to within 12 months (a possible 2453.19% upside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for InMed Pharmaceuticals (INM)?

The stock price for InMed Pharmaceuticals (NASDAQ: INM) is $0.235 last updated Today at April 26, 2024 at 4:51 PM EDT.

Does InMed Pharmaceuticals (INM) pay a dividend?

There are no upcoming dividends for InMed Pharmaceuticals.

When is InMed Pharmaceuticals (NASDAQ:INM) reporting earnings?

InMed Pharmaceuticals’s Q3 earnings are confirmed for Monday, May 13, 2024.

Is InMed Pharmaceuticals (INM) going to split?

There is no upcoming split for InMed Pharmaceuticals.

What sector and industry does InMed Pharmaceuticals (INM) operate in?

InMed Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.